Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes
- DOI
- 10.2174/0113895575414838251205172531
- Published
- 2026-09
- Container
- Mini-Reviews in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2174/0113895575414838251205172531,
title = {Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes},
author = {Md. Shoaib Alam and Sheikh Shafiq-un-Nabi and Veeraraghavan Gayathri and Saba Maanvizhi and Javed Ahmad and Arif Ansari and Ayesha Akhtar},
year = {2026},
journal = {Mini-Reviews in Medicinal Chemistry},
doi = {10.2174/0113895575414838251205172531},
url = {https://doi.org/10.2174/0113895575414838251205172531}
}RIS
TY - JOUR TI - Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes AU - Md. Shoaib Alam AU - Sheikh Shafiq-un-Nabi AU - Veeraraghavan Gayathri AU - Saba Maanvizhi AU - Javed Ahmad AU - Arif Ansari AU - Ayesha Akhtar PY - 2026 JO - Mini-Reviews in Medicinal Chemistry DO - 10.2174/0113895575414838251205172531 UR - https://doi.org/10.2174/0113895575414838251205172531 ER -
APA
Alam, M. S., Shafiq-un-Nabi, S., Gayathri, V., Maanvizhi, S., Ahmad, J., Ansari, A., & Akhtar, A. (2026). Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes. Mini-Reviews in Medicinal Chemistry. https://doi.org/10.2174/0113895575414838251205172531
Source records
- crossref · retrieved 2026-11-10T20:35:21.914Z